rs464605

GWAS Catalog Trait Associations (15)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

type 2 diabetes mellitus

Allele C
OR 0.07
p 8.0e-66
N 1,407,282
Meta-analysisLarge GWAS
multi-ancestry

cholesteryl esters to total lipids in small VLDL percentage

Zoodsma M et al. A genetic map of human metabolism across the allele frequency spectrum. Nature Genetics 57(10):2445-2455 (2025)
Allele T
OR 0.03
p 2.0e-30
N 450,015
Large GWAS
multi-ancestry

cholesterol to total lipids in small HDL percentage

Zoodsma M et al. A genetic map of human metabolism across the allele frequency spectrum. Nature Genetics 57(10):2445-2455 (2025)
Allele T
OR 0.03
p 6.0e-30
N 450,015
Large GWAS
multi-ancestry

Drugs used in diabetes use measurement

Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele T
OR 0.07
p 4.0e-19
N 484,639
Large GWAS
multi-ancestry
Allele T
OR 0.09
p 6.0e-10
N 305,913
Major Consortium StudyLarge GWAS
European

hemoglobin measurement

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele T
OR 0.02
p 3.0e-18
N 408,112
Large GWAS
European
Allele T
OR 0.01
p 3.0e-13
N 928,679
Large GWAS
multi-ancestry

systolic blood pressure

Allele T
OR 0.01
p 9.0e-15
N 928,679
Large GWAS
multi-ancestry
Allele T
OR 0.01
p 1.0e-8
N 1,212,859
Large GWAS
European
Allele T
OR 0.21
p 1.0e-14
N 1,028,980
Large GWAS
multi-ancestry

platelet component distribution width

Allele T
OR 0.02
p 4.0e-13
N 394,642
Large GWAS
European

apolipoprotein F measurement

Allele T
OR 0.04
p 5.0e-13
N 47,745
Large GWAS
European

high density lipoprotein cholesterol measurement

Allele T
OR 0.01
p 1.0e-12
N 394,642
Large GWAS
European

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…